Northwestern Medicine investigators have uncovered a missing link behind the harmful effects of autoantibodies linked to ...

The article, titled "Emerging roles of immune cell-derived neurotransmitters in immunity and disease," published on March 17, ...

T cell activation—the process by which these key immune defenders recognize threats and mobilize against them—depends on exquisitely timed molecular signals. Now researchers have captured one of the ...

The article, titled "Emerging roles of immune cell-derived neurotransmitters in immunity and disease," published on March 17, 2026, in Immunity ...

Explore how human-relevant tumor models like 3D cultures, organoids, organ-on-chip platforms, and the 3MIC system are ...

GRANDEVITY Definition: "Great Age, Long Life, Longevity" SAN DIEGO, April 3, 2026 /PRNewswire/ -- Today, GRANDEVITY officially launches as a premium plant-based wellness brand dedicated to helping ...

Macrophages, the immune system’s front-line scavenger cells, do more than simply digest dead cells. A new study published in ...

("Olatec"), developing one of the most clinically advanced specific oral NLRP3 inhibitors, dapansutrile, today announced that two patients have been randomized in a 12-month clinical trial, named DAPA ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that data from the Phase 3 study of vilobelimab ...

Additions Bring Extensive Capital Markets and Business Transaction Expertise to Company as it Advances Pegtarazimod into Late-Stage Clinical TrialsNORFOLK, Va.--(BUSINESS WIRE)--ReAlta Life Sciences ...

Closed upsized initial public offering in February 2026, raising $381 million in gross proceedsCompleted enrollment of the TeLuRide-005 Phase 2 trial of EIK1001 in first-line treatment of stage 4 ...